Dipeptidyl peptidase-4 inhibitors, a class of hypoglycemics taken orally, block DPP-4, which is also known as adenosine deaminase complexing protein 2. It is believed that the use of DPP-4 inhibitors increase incretin levels which inhibit glucagon release which in turn decreases blood glucose.
Regular Websites
DDP-4 Inhibitors fo rTpe 2 Diabetes Mellitus
Overview of the article about the research consists of the abstract, background, objectives and search strategy as well as the results and authors' conclusions. - DDP-4 Inhibitors fo rTpe 2 Diabetes Mellitus
http://www.cochrane.org/reviews/en/ab006739.html
The manufacturers of sitagliptin tablets present details about their product and how it works, the difference between sitagliptin and other drugs, and how to manage type 2 diabetes. - Nanuvia
http://www.januvia.com/sitagliptin/januvia/consumer/index.jsp